Ando M - Search Results

1

The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function.

Yamamoto N, Tamura T, Maeda M, Ando M, Shinkai T, Eguchi K, Ohe Y, Oshita F, Shiraishi J, Katsumata N, et al. Yamamoto N, et al. Among authors: ando m. Cancer Chemother Pharmacol. 1995;36(2):102-6. doi: 10.1007/BF00689192. Cancer Chemother Pharmacol. 1995. PMID: 7767944

2

Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer.

Sato M, Ando M, Minami H, Ando Y, Ando M, Yamamoto M, Sakai S, Watanabe A, Ikeda T, Sekido Y, Saka H, Shimokata K, Hasegawa Y. Sato M, et al. Among authors: ando y, ando m. Cancer Chemother Pharmacol. 2001 Dec;48(6):481-7. doi: 10.1007/s002800100355. Cancer Chemother Pharmacol. 2001. PMID: 11800029 Clinical Trial.

3

In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under the c/t curve.

Kobayashi K, Kudoh S, Takemoto T, Hino M, Hayashihara K, Nakahiro K, Ando M, Niitani H. Kobayashi K, et al. Among authors: ando m. J Cancer Res Clin Oncol. 1995;121(12):715-20. doi: 10.1007/BF01213317. J Cancer Res Clin Oncol. 1995. PMID: 7499442

4

Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study.

Yoshioka H, Okamoto I, Morita S, Ando M, Takeda K, Seto T, Yamamoto N, Saka H, Atagi S, Hirashima T, Kudoh S, Satouchi M, Ikeda N, Iwamoto Y, Sawa T, Nakanishi Y, Nakagawa K. Yoshioka H, et al. Among authors: ando m. Ann Oncol. 2013 May;24(5):1326-31. doi: 10.1093/annonc/mds629. Epub 2012 Dec 30. Ann Oncol. 2013. PMID: 23277482 Free article. Clinical Trial.

5

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).

Yamazaki K, Nagase M, Tamagawa H, Ueda S, Tamura T, Murata K, Eguchi Nakajima T, Baba E, Tsuda M, Moriwaki T, Esaki T, Tsuji Y, Muro K, Taira K, Denda T, Funai S, Shinozaki K, Yamashita H, Sugimoto N, Okuno T, Nishina T, Umeki M, Kurimoto T, Takayama T, Tsuji A, Yoshida M, Hosokawa A, Shibata Y, Suyama K, Okabe M, Suzuki K, Seki N, Kawakami K, Sato M, Fujikawa K, Hirashima T, Shimura T, Taku K, Otsuji T, Tamura F, Shinozaki E, Nakashima K, Hara H, Tsushima T, Ando M, Morita S, Boku N, Hyodo I. Yamazaki K, et al. Among authors: ando m. Ann Oncol. 2016 Aug;27(8):1539-46. doi: 10.1093/annonc/mdw206. Epub 2016 May 13. Ann Oncol. 2016. PMID: 27177863 Free article. Clinical Trial.

6

Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer.

Ando Y, Minami H, Saka H, Ando M, Sakai S, Shimokata K. Ando Y, et al. Among authors: ando m. Jpn J Cancer Res. 1996 Feb;87(2):200-5. doi: 10.1111/j.1349-7006.1996.tb03159.x. Jpn J Cancer Res. 1996. PMID: 8609070 Free PMC article. Clinical Trial.

7

[A case of advanced gastric cancer treated with neoadjuvant chemotherapy of low-dose CPT-11 + CDDP].

Tadatomo H, Suzuki K, Ando M, Yamashita S, Tanaka K, Maruyama S, Harada Y, Ohnuma S, Sakaniwa N, Koyanagi Y. Tadatomo H, et al. Among authors: ando m. Gan To Kagaku Ryoho. 2001 Jun;28(6):821-4. Gan To Kagaku Ryoho. 2001. PMID: 11432351 Japanese.

8

Estimation of the area under the concentration-versus-time curve of carboplatin following irinotecan using a limited sampling model.

Asai G, Ando Y, Saka H, Ando M, Sugiura S, Sakai S, Hasegawa Y, Shimokata K. Asai G, et al. Among authors: ando y, ando m. Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):725-7. doi: 10.1007/s002280050542. Eur J Clin Pharmacol. 1998. PMID: 9923575 Clinical Trial.

9

Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.

Ando Y, Minami H, Saka H, Ando M, Sakai S, Shimokata K. Ando Y, et al. Among authors: ando m. Br J Cancer. 1997;76(8):1067-71. doi: 10.1038/bjc.1997.509. Br J Cancer. 1997. PMID: 9376268 Free PMC article.

10

Prognostic value of pleural effusion in patients with non-small cell lung cancer.

Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K. Sugiura S, et al. Among authors: ando y, ando m. Clin Cancer Res. 1997 Jan;3(1):47-50. Clin Cancer Res. 1997. PMID: 9815536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,471 results

Search Page

Filters